Pages

Thursday, September 21, 2017

Procter & Gamble (PG) Dividend Stock Analysis

Linked here is a detailed quantitative analysis of Procter & Gamble (PG). Below are some highlights from the above linked analysis:

Company Description: The Procter & Gamble Company is a leading consumer products company that markets household and personal care products in more than 180 countries.

Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description:

1. Avg. High Yield Price
2. 20-Year DCF Price
3. Avg. P/E Price
4. Graham Number

PG is trading at a premium to all four valuations above. Since PG's tangible book value is not meaningful, a Graham number can not be calculated. When also considering the NPV MMA Differential, the stock is trading at a 36.2% premium to its calculated fair value of $68.48. PG did not earn any Stars in this section.

Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description:

1. Free Cash Flow Payout
2. Debt To Total Capital
3. Key Metrics
4. Dividend Growth Rate
5. Years of Div. Growth
6. Rolling 4-yr Div. > 15%

PG earned two Stars in this section for 2.) and 3.) above. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. PG earned a Star for having an acceptable score in at least two of the four Key Metrics measured. The company has paid a cash dividend to shareholders every year since 1891 and has increased its dividend payments for 60 consecutive years.

Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description:

1. NPV MMA Diff.
2. Years to > MMA

The NPV MMA Diff. of the $225 is below the $500 target I look for in a stock that has increased dividends as long as PG has. The stock's current yield of 2.96% exceeds the 2.65% estimated 20-year average MMA rate.

Peers: The company’s peer group includes: Clorox Corporation (CLX) with a 2.5% yield, Colgate-Palmolive Co. (CL) with a 2.2% yield, and Kimberly-Clark Corporation (KMB) with a 3.2% yield.

Conclusion: PG did not earn any Stars in the Fair Value section, earned two Stars in the Dividend Analytical Data section and did not earn any Stars in the Dividend Income vs. MMA section for a total of two Stars. This quantitatively ranks PG as a 2-Star Weak stock.

Using my D4L-PreScreen.xls model, I determined the share price would need to decrease to $74.22 before PG's NPV MMA Differential increased to the $500 minimum that I look for in a stock with 60 years of consecutive dividend increases. At that price the stock would yield 3.7%.

Resetting the D4L-PreScreen.xls model and solving for the dividend growth rate needed to generate the target $500 NPV MMA Differential, the calculated rate is 4.3%. This dividend growth rate is higher than the 1.9% used in this analysis, thus providing no margin of safety. PG has a risk rating of 1.75 which classifies it as a Medium risk stock.

The company is working to become a more nimble and responsive competitor in the global consumer products market. Its free cash flow payout at 81% (up from 76% in the previous review) is above the 60% maximum that I prefer. This is offset with a low debt to total capital of 36% (flat). PG is trading well above my calculated fair value of $68.48. For now, I will wait for a more opportune time before adding to my position.

Disclaimer: Material presented here is for informational purposes only. The above quantitative stock analysis, including the Star rating, is mechanically calculated and is based on historical information. The analysis assumes the stock will perform in the future as it has in the past. This is generally never true. Before buying or selling any stock you should do your own research and reach your own conclusion. See my Disclaimer for more information.

Full Disclosure: At the time of this writing, I was long PG (4.9% of my Dividend Growth Portfolio) and long KMB, CL. See a list of all my Dividend Growth Portfolio holdings here.

Related Articles:
- Colgate-Palmolive (CL) Dividend Stock Analysis
- Union Pacific Corporation (UNP) Dividend Stock Analysis
- Abbvie Inc. (ABBV) Dividend Stock Analysis
- Nike, Inc. (NKE) Dividend Stock Analysis
- Omega Healthcare Investors, Inc. (OHI) Dividend Stock Analysis
- More Stock Analysis


Tags: PG, CLX, CL, KMB,